Průměr hodnocení společnosti Acorda Therapeutics Inc
Jaká je hodnota metriky Průměr hodnocení společnosti Acorda Therapeutics Inc?
Hodnota metriky Průměr hodnocení společnosti Acorda Therapeutics Inc je 2.33
Jaká je definice metriky Průměr hodnocení?
Průměr hodnocení (Recommendation mean) je průměr hodnocení analytiků akcií společnosti, který se pohybuje mezi 1.0 (rozhodně koupit) a 5.0 (rozhodně prodat).
Mean of recommendations is an average of ratings from different analysts but it should still be used with other research and investment metrics in order to make investment decisions. It is important to understand a firm's entire scale when assimilating ratings. Additionally, analyst recommendations on stocks owned by firms employing them may be seen as potentially biased.
Financial analysts are often employed by mutual and pension funds, hedge funds, securities firms, banks, investment banks, insurance companies, and other businesses, helping these companies or their clients make investment decisions. Financial analysts employed in commercial lending perform "balance sheet analysis," examining the audited financial statements and corollary data in order to assess lending risks. In a stock brokerage house or in an investment bank, they read company financial statements and analyze commodity prices, sales, costs, expenses, and tax rates in order to determine a company's value and project future earnings. In any of these various institutions, the analyst often meets with company officials to gain a better insight into a company's prospects and to determine the company's managerial effectiveness.
Usually, financial analysts study an entire industry, assessing current trends in business practices, products, and industry competition. They must keep abreast of new regulations or policies that may affect the industry, as well as monitor the economy to determine its effect on earnings.
Průměr hodnocení společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Acorda Therapeutics Inc
Čemu se věnuje společnost Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Firmy s metrikou průměr hodnocení podobnou společnosti Acorda Therapeutics Inc
- Hodnota metriky Průměr hodnocení společnosti Fox je 2.32
- Hodnota metriky Průměr hodnocení společnosti Dicks Sporting Goods je 2.32
- Hodnota metriky Průměr hodnocení společnosti Fortinet Inc je 2.32
- Hodnota metriky Průměr hodnocení společnosti Oracle je 2.32
- Hodnota metriky Průměr hodnocení společnosti Verizon Communications Inc je 2.32
- Hodnota metriky Průměr hodnocení společnosti Bank Of New York Mellon Corp je 2.32
- Hodnota metriky Průměr hodnocení společnosti Acorda Therapeutics Inc je 2.33
- Hodnota metriky Průměr hodnocení společnosti APA je 2.34
- Hodnota metriky Průměr hodnocení společnosti Huntington Bancshares je 2.35
- Hodnota metriky Průměr hodnocení společnosti Pentair plc je 2.35
- Hodnota metriky Průměr hodnocení společnosti Banco Bilbao Vizcaya Argentaria S.A je 2.35
- Hodnota metriky Průměr hodnocení společnosti Healthcare Realty Trust Inc je 2.36
- Hodnota metriky Průměr hodnocení společnosti Azul S.A je 2.36